1-5 of 5
Almut G. Winterstein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Associations Between Postdischarge Care and Cognitive Impairment–Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With Diabetes

Free
Yehua Wang, Tianze Jiao, Matthew R. Muschett, Joshua D. Brown, Serena Jingchuan Guo, Ambar Kulshreshtha, Yongkang Zhang, Almut G. Winterstein, Hui Shao
Journal: Diabetes Care
Diabetes Care 2024;47(2):225–232
https://doi.org/10.2337/dca23-0013
Published: 04 December 2023
View articletitled, Associations Between Postdischarge Care and Cognitive Impairment–Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With Diabetes
Open the PDF for Associations Between Postdischarge Care and Cognitive Impairment–Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With Diabetes in another window
Journal Articles

A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments

Free
Almut G. Winterstein, Vera Ehrenstein, Jeffrey S. Brown, Til Stürmer, Meredith Y. Smith
Journal: Diabetes Care
Diabetes Care 2023;46(8):1448–1454
https://doi.org/10.2337/dc22-2037
Published: 20 July 2023
View articletitled, A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments
Open the PDF for A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments in another window
Journal Articles

Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials

Free
Huilin Tang, Stephen E. Kimmel, Steven M. Smith, Kenneth Cusi, Weilong Shi, Matthew Gurka, Almut G. Winterstein, Jingchuan Guo
Journal: Diabetes Care
Diabetes Care 2022;45(4):1007–1012
https://doi.org/10.2337/dc21-1722
Published: 29 March 2022
View articletitled, Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials
Open the PDF for Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials in another window
Journal Articles

Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352

Free
Yasser Albogami, Kenneth Cusi, Michael J Daniels, Yu-Jung J. Wei, Almut G. Winterstein
Journal: Diabetes Care
Diabetes Care 2021;44(8):e167
https://doi.org/10.2337/dci21-0024
Published: 11 August 2021
View articletitled, Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352
Open the PDF for Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 in another window
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes

Free
Yasser Albogami, Kenneth Cusi, Michael J. Daniels, Yu-Jung J. Wei, Almut G. Winterstein
Journal: Diabetes Care
Diabetes Care 2021;44(6):1344–1352
https://doi.org/10.2337/dc20-1794
Published: 19 April 2021
View articletitled, Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes in another window